196 related articles for article (PubMed ID: 34668237)
1. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
Turlier V; Darde MS; Loustau J; Mengeaud V
J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
[TBL] [Abstract][Full Text] [Related]
2. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
3. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
[TBL] [Abstract][Full Text] [Related]
4. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study.
Rossi A; Magri F; DI Fraia M; Caro G; Fortuna MC; Piacentini M; Celleno L
Ital J Dermatol Venerol; 2022 Feb; 157(1):78-83. PubMed ID: 33878855
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti-inflammatory and antioxidant agents to treat hair loss.
Anzai A; Pereira AF; Malaquias KR; Guerra LO; Mercuri M
Dermatol Ther; 2020 May; 33(3):e13293. PubMed ID: 32134172
[TBL] [Abstract][Full Text] [Related]
6. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
Zímová J; Zímová P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
El-Dawla RE; Abdelhaleem M; Abdelhamed A
Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
Milani M; Colombo F;
Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 infection is a major cause of acute telogen effluvium.
Sharquie KE; Jabbar RI
Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
[TBL] [Abstract][Full Text] [Related]
10. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
[TBL] [Abstract][Full Text] [Related]
11. Acute telogen effluvium triad after resolution.
Contin LA; Rocha VB
An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
[TBL] [Abstract][Full Text] [Related]
12. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
[TBL] [Abstract][Full Text] [Related]
13. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.
Cedirian S; Bruni F; Quadrelli F; Caro G; Fortuna M; Rossi A; Piraccini BM; Starace M
J Cosmet Dermatol; 2023 Dec; 22(12):3347-3351. PubMed ID: 37415302
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of QR678 Neo
Shome D; Kapoor R; Surana M; Vadera S; Shah R
J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
[TBL] [Abstract][Full Text] [Related]
16. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
Feaster B; Onamusi T; Cooley JE; McMichael AJ
Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
[TBL] [Abstract][Full Text] [Related]
17. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S
J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471
[TBL] [Abstract][Full Text] [Related]
18. Recent modalities in treatment of telogen effluvium: Comparative study.
Khattab FM; Rady A; Khashaba SA
Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
[TBL] [Abstract][Full Text] [Related]
19. Anagen effluvium.
Kanwar AJ; Narang T
Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
